Adherence and positivity rates were consistently high during four rounds of screening.
The fecal immunochemical test (FIT) is receiving increasing attention as an effective method of colorectal cancer screening. However, few data are available on the yield of repeated rounds of FIT screening.
To prospectively evaluate participation rates, positivity rates, and cancer yields from repeated FIT screening, investigators invited 2959 people aged 50 to 74 in a region of Italy to participate in screening using a quantitative FIT. Those eligible were invited to participate in three subsequent rounds of screening during 7 years.
Overall, 73% of the original invited population participated in at least one test, 48% participated in all four tests, and the adherence rate for each round ranged from 56% to 63%. The positivity rate with a cutoff of 100 ng hemoglobin/mL buffer remained consistent in the four rounds of screening (4.3%, 4.2%, 3.7%, and 4.4%). The detection rate for advanced neoplasia was 1.5% in the first round and 1.3% in each of the subsequent three rounds. The cumulative detection rate for advanced neoplasia (advanced adenomas or cancer) was 3.5%.
Reviewing Author
DisclosuresConsultant/Advisory BoardOlympus Corporation America; Boston Scientific
Speaker’s BureauOlympus
Grant/Research SupportMedtronic; Boston Scientific; Colonary Solutions; Paion Medical; Medivators; Braintree Laboratories
Editorial BoardsWorld Journal of Gastroenterology; The Journal of Clinical Gastroenterology; Techniques in Gastrointestinal Endoscopy; Gastroenterology & Hepatology; Expert Review of Gastroenterology & Hepatology; Medscape Gastroenterology; World Journal of Gastrointestinal Pharmacology and Therapeutics; Annals of Gastroenterology & Hepatology; World Journal of Gastrointestinal Oncology; Comparative Effectiveness Research; Journal of Anesthesia & Clinical Research; Gastroenterology; World Journal of Gastrointestinal Pathophysiology; Gastroenterology Research and Practice; GI & Hepatology News; Gastroenterology Report; Clinical Epidemiology Reviews; JSM Gastroenterology and Hepatology; GI Journal Watch; Austin Journal of Gastroenterology; World Journal of Gastrointestinal Pharmacology & Therapeutics
Leadership Positions in Professional SocietiesAmerican Society for Gastrointestinal Endoscopy (Treasurer); US Multi-Society Task Force (AGA, ACG, ASGE) (Chair)
DisclosuresConsultant/Advisory BoardOlympus Corporation America; Boston Scientific
Speaker’s BureauOlympus
Grant/Research SupportMedtronic; Boston Scientific; Colonary Solutions; Paion Medical; Medivators; Braintree Laboratories
Editorial BoardsWorld Journal of Gastroenterology; The Journal of Clinical Gastroenterology; Techniques in Gastrointestinal Endoscopy; Gastroenterology & Hepatology; Expert Review of Gastroenterology & Hepatology; Medscape Gastroenterology; World Journal of Gastrointestinal Pharmacology and Therapeutics; Annals of Gastroenterology & Hepatology; World Journal of Gastrointestinal Oncology; Comparative Effectiveness Research; Journal of Anesthesia & Clinical Research; Gastroenterology; World Journal of Gastrointestinal Pathophysiology; Gastroenterology Research and Practice; GI & Hepatology News; Gastroenterology Report; Clinical Epidemiology Reviews; JSM Gastroenterology and Hepatology; GI Journal Watch; Austin Journal of Gastroenterology; World Journal of Gastrointestinal Pharmacology & Therapeutics
Leadership Positions in Professional SocietiesAmerican Society for Gastrointestinal Endoscopy (Treasurer); US Multi-Society Task Force (AGA, ACG, ASGE) (Chair)
Citation(s):
Crotta S et al. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol 2012 Jun; 10:633.
Comment
These results describe consistently high adherence rates, positive predictive values, and detection rates for advanced neoplasia of fecal immunochemical testing in four rounds of approximately biennial screening. The findings are encouraging with regard to the effectiveness of repeated FIT screening, even though the cumulative detection rate for advanced neoplasia is considerably lower than would be expected from a single round of screening colonoscopy, and data on detection of serrated lesions are not provided.